期刊文献+

弱阳离子交换整体柱的制备及其对人血浆中硝苯地平的在线分析 被引量:3

Preparation of weak cation exchange monolithic column and its applications for on-line determination of nifedipine in human plasma
下载PDF
导出
摘要 以甲基丙烯酸(MAA)为功能单体,乙二醇二甲基丙烯酸酯(EDMA)为交联剂,以色谱柱管为模具,通过原位聚合法制备了弱阳离子交换整体柱。该柱能去除血浆中的内源性物质,对生物样品中的药物有富集作用。将其作为固相萃取柱与C18色谱柱联用,在线分析了人血浆中的硝苯地平。流动相为甲醇-水(体积比为70∶30),流速1.0mL/min,检测波长235nm。结果表明,硝苯地平在5.0~75.0μg/L范围内线性关系良好(r=0.999 3),方法的回收率为90.0%~99.0%,日内、日间相对标准偏差均小于5.0%。该方法精密度高,重现性良好,避免了繁琐的样品预处理过程,且弱离子整体柱可多次重复使用,为检测血浆中的痕量药物提供了一种快速、经济、有效的新方法。 A cation exchange monolithic column was prepared with methylacrylic acid(MAA) as the functional monomer and ethylene dimethacrylate(EDMA) as the cross linker.This column was applied to remove the matrix compounds and enrich the ionic medicines in human plasma with water as the mobile phase.As a result,the human plasma samples can be directly injected into chromatographic system.The relationship between the mobile phase flow rate and back pressure was studied.The results showed that the monolithic column had good performances in lower pressure and higher permeability.In addition,the maximum adsorption of nifedipine on this monolithic column was investigated.The on-line clean-up and enrichment of samples were carried out using this column as the solid-phase extraction material and the C18 column as the analytical column.The chromatography was performed on a C18 reversed-phase high performance liquid chromatographic column with ultraviolet detection at 235 nm.The mobile phase was a mixture of methanol-water(70∶30,v/v),and the flow rate was 1.0 mL/min.The linear range of nifedipine in human plasma was 5.0-75.0 μg/L.The intra-and inter-day relative standard deviations(RSDs) were both less than 5.0%.The limit of detection(LOD) was 1 μg/L and the limit of quantification(LOQ) was 4 μg/L.In this method tedious pretreatment procedure is not necessary.It is a fast,economical,reproducible and efficient method for assaying trace nifedipine in human plasma.
出处 《色谱》 CAS CSCD 北大核心 2009年第2期197-200,共4页 Chinese Journal of Chromatography
基金 国家自然科学基金(No.20375010,20675084) 河北省科技攻关(No.06276479B,07276407D) 中国科学院“百人计划”项目
关键词 离子交换整体柱 在线分析 硝苯地平 血浆 ion exchange monolithic column on-line analysis nifedipine human plasma
  • 相关文献

参考文献13

二级参考文献38

  • 1徐凯建,张慧君,陆义诚,吴琳华,孙考祥,胡君茹.心痛定片剂与滴丸的人体生物利用度及药代动力学的研究[J].中国医院药学杂志,1994,14(3):106-108. 被引量:4
  • 2葛庆华,王浩,傅民,周臻,何广安,刘戈,江志强.国产硝苯地平控释片的药动学和生物等效性研究[J].高血压杂志,2005,13(5):310-312. 被引量:19
  • 3马骏,谢景文,贾正平,宋岭,许顺尧,赵德化.间硝苯地平在兔体内的药物动力学(英文)[J].中国药理学报,1996,17(2):109-111. 被引量:2
  • 4古宏标,汤聿海,徐毅.间硝苯地平对血管紧张素Ⅱ促进血管平滑肌细胞增殖和蛋白质合成的影响[J].药学学报,1996,31(10):732-736. 被引量:4
  • 5戴玉华 余国膺.1995年关于钙拮抗剂的一场争论[J].医学进展,1996,1(2):3-3.
  • 6[1] Ali SL.Nifedipine.In:Florey K,et al.A nalytical Profiles of Drug Substances[M].Vol 18.San Diego:Academic Press,1 989:211~288.
  • 7[2] Reynolds JEF,Martindale:the extra pharmac opoeia [M].31ed.London:Royal Pharmaceutical society of Great Britain,1996:916 ~921.
  • 8[3] Sorkin EM,Clissold SP,Brogden RN.Nifedipi ne:a review of its pharmacodynamic and pharmacokinetic properties,and therapeuti c efficacy,in ischaemic heart disease,hypertension and related cardiovascacular disorders[J].Drugs,1985,30:182.
  • 9[4] Troger U,Martens J,Meyer FP,et al.Stu dy on the bioequivalence of an oral nifedipine formulation and a sustained relea se preparation after single dose and repeated doses[J].Arzneim-Forsch/Drug Res,1995,45(Ⅱ):1266.
  • 10[5] Lutz D,Ilias E,Jaeger H.Automated Determi nation of nifedipine in human plasma by capillary gas chromatography with electr on capture detection[J].J High Resolution Chromatography and Chromatogr Comm un,1986,9(7):397.

共引文献38

同被引文献76

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部